Stock data
UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN) reported revenue of US$109.79M and net income of -US$153.49M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$109.79M | US$97.34M | -US$124.86M | -US$153.49M | — |
| 2024 | US$90.40M | US$81.52M | -US$96.78M | -US$126.87M | — |
| 2023 | US$82.71M | US$73.35M | -US$65.54M | -US$102.24M | — |
| 2022 | US$64.36M | US$56.70M | -US$79.04M | -US$109.78M | — |
| 2021 | US$48.04M | US$42.88M | -US$92.29M | -US$110.82M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$72.46M | -US$14.35M | — |
| 2026-03-31 | US$50.96M | -US$23.57M | — |
| 2025-12-31 | US$37.84M | -US$26.36M | — |
| 2025-09-30 | US$27.48M | -US$33.35M | — |
| 2025-06-30 | US$24.21M | -US$49.94M | — |
| 2025-03-31 | US$20.25M | -US$43.84M | — |
| 2024-12-31 | US$24.57M | -US$37.51M | — |
| 2024-09-30 | US$25.20M | -US$23.67M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.